Antibiotice Iasi, one of the most important players in the local pharmaceutical industry and the main producer of the active substance nystatin globally, ended the first nine months with sales revenues of 242 million lei, a level comparable to that of 2018, and a net profit of 21.5 million lei, with about 2% over the similar period of last year, shows the data published on Friday at the BSE.

https://www.zf.ro/companii/antibiotice-iasi-vanzari-de-242-mil-lei-la-9-luni-si-profit-net-de-21-5-mil-lei-in-crestere-cu-2-18587920